Future directions in asthma therapy: Is a cure possible?

Chest

Volumn 111, Issue 2 SUPPL., 1997, Pages 61S-68S

  Leff, Alan R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

asthma; asthma cure; asthma gene; asthma mortality; bronchoconstriction; eosinophil; leukotriene; leukotriene receptor antagonist

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOSPORIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTAMINE; INDOMETACIN; INTERFERON; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; METHACHOLINE; N [1 (4 BENZYLOXYPHENYL)ETHYL]ACETOHYDROXAMIC ACID; PROSTAGLANDIN SYNTHASE INHIBITOR; SLOW REACTING SUBSTANCE; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR;

ARTICLE; ASTHMA; AUTONOMIC HYPERREFLEXIA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; DRUG TARGETING; FORCED EXPIRATORY VOLUME; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY TRACT INFLAMMATION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0031051012     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Leff AR. Toward the formulation of a theory of asthma. Perspect Biol Mod 1990; 33:292-302
2. Leff AH. Endogenous regulation of bronchomotor tone. Am Rev Respir Dis 1988; 137:1198-1216
3. Orange HP, Austen WG, Austen KF. Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung: I. Modulation by agents influencing cellular levels of cyclic 3′,5′-adenosine monophosphate. J Exp Med 1971; 134(3 suppl):136S-48S
4. Gold WM. Neurohumoral interactions in airways. Am Rev Respir Dis 1977; 115(6 pt 2): 127-37
5. Kaliner M, Orange HP, Austen KF. Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. J Exp Med 1972; 136:556-67
6. Aizawa T, Sekizawa K, Aikawa T, et al. Eosinophil supernatant causes hyperresponsiveness of airway smooth muscle in guinea pig trachea. Am Rev Respir Dis 1990; 142:133-37
7. Gleich GJ, Flavahan NA, Fujisawa T, et al. The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. J Allergy Clin Immunol 1988; 81(5 pt 1):776-81
8. Hamann KJ, Strek ME, Baranowski SL, et al. Effects of activated eosinophils cultured from human umbilical cord blood on guinea pig trachealis. Am J Physiol 1993; 265(3 pt 1):L301-07
9. Rabe KF, Muñoz NM, Vita AJ, et al. Contraction of human bronchial smooth muscle caused by activated human eosinophils. Am J Physiol 1994; 267
10. (Lung Cell Mol Physiol 11): L326-34
11. Lockhart A. What is bronchial asthma?: the role of genetic and acquired factors. In: Marsh DG, Lockhart A, Holgate ST, eds. The genetics of asthma. London: Blackwell Scientific Publications, 1993; 3-14
12. Sands MF, Douglas FL, Green J, et al. Homeostatie regulation of bronchomotor tone by sympathetic activation during bronchoconstriction in normal and asthmatic humans. Am Rev Respir Dis 1985; 132:993-98
13. Pearee NE, Beasley R, Crane J, et al. Epidemiology of asthma mortality. In: Busse WW, Holgate ST, eds. Asthma and rhinitis. Boston: Blackwell Scientific Publications, 1995; 58-69
14. Jackson R, Sears MR, Beaglehole R, et al. International trends in asthma mortality: 1970 to 1985. Chest 1988; 94: 914-18
15. Corrigan CJ, Kay AB. The lymphocyte in asthma. In: Busse WW, Holgate SJ, eds. Asthma and rhinitis. Boston: Blackwell Scientific Publications, 1995; 450-64
16. Leff AR. Pathophysiology of asthmatic bronchoconstriction. Chest 1982; 82(1 suppl):13S-21S
17. Alexander AG, Barnes NC, Kay AB. Trial of cyclosporin in corticosteroid-dcpendent chronic severe asthma. Lancet 1992; 339:324-28
18. Strek ME, White SR, Hsiue TR, et al. Effect of mode of activation of human eosinophils on tracheal smooth muscle contraction in guinea pigs. Am J Physiol 1993; 264(5 pt 1):L475-81
19. Strek ME. Leukotriene receptor blockers and synthesis inhibitors in asthma. In: Leff AR, ed. Pulmonary pharmacology and therapeutics. New York: McGraw-Hill, 1996; 649-62